Spotlight on the new ACC/AHA lipid and JNC8 hypertension guidelines, EGFR inhibitors vs chemotherapy for NSCLC, and more.

JAMA Editors' Summary - A podcast by JAMA Network - Fridays

Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the April 09, 2014 issue